2024年5月6日 · Glioblastoma multiforme (GBM) is the most malignant and pervasive subtype of glioma and is the most common primary brain tumor in adults. It remains an incurable disease …

2017年9月27日 · Glioblastoma (GBM) is the most aggressive diffuse glioma of astrocytic lineage and is considered a grade IV glioma based on the WHO classification (1). GBM is the most …

The mean age of primary GBM presentation is 62 years, and the median survival is approximately 14.6 months [1,3]. The poor prognosis associated with GBM is well documented, while survival …

Glioblastoma multiforme (GBM) is a WHO grade IV glioma and the most common malignant, primary brain tumor with a 5-year survival of 7.2%. Its highly infiltrative nature, genetic …

2024年5月6日 · Glioblastoma multiforme (GBM) comprises glioma's most malignant and pervasive subtype. GBM is the most common primary brain tumor in adults, accounting for …

This review describes how STAT-3 activation and resulting downstream effects play a role in GBM progression, and how therapeutic strategies to inhibit STAT-3 signaling provide new …

2025年3月26日 · Glioblastoma (GBM) is a primary malignant brain tumor of the central nervous system, with a high degree of malignancy and an annual incidence of 3–5 per 100,000 people …

2025年2月26日 · Glioblastoma multiforme (GBM) is the most prevalent and aggressive primary brain tumor in adults, characterized by a poor prognosis and significant resistance to existing …

2025年3月28日 · Glioblastoma (GBM) is the most common and lethal brain tumor with limited therapeutic strategies and incomplete studies on its progression and mechanisms. ... Statistics …

2024年7月17日 · Glioblastoma (GBM) is one of the most complex, deadly, and treatment-resistant cancers. More than 14,490 Americans are expected to receive a GBM diagnosis in 2023. GBM …